Actualités ac463/1523404
Leap Therapeutics, Inc. (LPTX)
Mon, 28 Oct 2024 09:00:00 GMT
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that enrollment of 188 patients has been completed ...